Delivery Order SPE2DR25D2014-SPE2DR26FZ73Q
Award Date 11/17/25
Potential Completion Date 11/18/25
Potential Value $16K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Zepbound 5 mg/0.5 ml pens with a ceiling value of $2,726.72. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and represents a non-set-aside competitive award. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $13,150.18 delivery order to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 ml pen injectors on September 9, 2025, with an ultimate completion date of September 10, 2025. This firm fixed-price delivery order, which was competitively awarded with no set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist used for weight management, reflecting the federal...
- The Defense Logistics Agency awarded a $23,139.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pen injectors on November 13, 2025, with an ultimate completion date of November 14, 2025. This contract was competitively awarded with no set-aside designation and represents a delivery order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $28,197.83 for Zepbound 10 mg/0.5 mL pens on July 17, 2025, with completion scheduled for July 18, 2025. This firm fixed-price, competitively awarded delivery order was issued without set-aside designation and will be performed at the contractor's corporate headquarters in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist used for weight management, reflecting the Defense Logistics Agency's...
- The Defense Logistics Agency awarded a delivery order valued at $10,110.02 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pens on October 22, 2025, with an ultimate completion date of October 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Zepbound, a GLP-1 receptor agonist used for weight management, represents part of the broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Zepbound 12.5 mg/0.5 ml pen injections, valued at $6,035.72. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist...
- The Defense Logistics Agency awarded a delivery order valued at $14,976.92 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injections on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist medication used for weight management, representing...
- The Defense Logistics Agency awarded a delivery order valued at $1,071.60 to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 mL pen injections on September 25, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 26, 2025. Zepbound is a GLP-1 receptor agonist used for weight management and is part of the broader...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $33,963.10 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pens on August 7, 2025, with completion expected by August 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist used for weight management and represents part of the...
- The Defense Logistics Agency awarded a delivery order valued at $1,284.26 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pens on April 21, 2025, with completion expected by April 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's facility in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist medication used in diabetes and weight management treatment, reflecting the...